How to Use an EpiPen

Scientists may have found a “unifying theory” of chronic fatigue October 2, 2026
Scientists found that five seemingly unrelated conditions, including long Covid, ME/CFS, and PTSD, may disrupt many of the same biological networks involved in immunity, metabolism, and cellular energy. The findings could help explain their shared symptoms and may open the door to new blood tests and treatments.
1 in 13 adults under 30 already had hidden artery plaque October 1, 2026
More than half of 16,000 apparently healthy adults had signs of atherosclerosis, with arterial plaques already detectable in about 1 in 13 people ages 18 to 29. Researchers say directly imaging the arteries could reveal hidden cardiovascular disease years or even decades before symptoms appear.
Pomegranate compound improves heart function by up to 80% in study September 28, 2026
A compound the body can make after eating pomegranates, walnuts, and some berries improved measures of heart function by up to 80% in animal models of a difficult-to-treat form of heart failure. Urolithin A helped stiff heart tissue relax and reduced scarring and abnormal enlargement. It also improved relaxation in engineered human heart tissue.
Scientists say house cats could help unlock better cancer treatments for humans September 27, 2026
Scientists have mapped the genetics of cat cancer on an unprecedented scale and found surprising similarities with tumors in humans. The findings could help bring precision cancer treatments to cats while also revealing new clues about how human cancers develop and respond to drugs.
That fresh cleaning smell could be filling your home with nanoparticles September 26, 2026
Researchers found that scented cleaners can react with ozone indoors to create billions or trillions of invisible nanoparticles that can penetrate deep into the lungs. The pollution forms within minutes and, in some cases, may produce an inhaled particle dose comparable to or greater than standing near heavy traffic.
Stopping Ozempic may raise heart attack and stroke risk September 21, 2026
A large study suggests the cardiovascular benefits of GLP-1 drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound can disappear surprisingly quickly when treatment stops. After two years off the medications, patients had a 22% higher risk of heart attack, stroke, and death compared with those who stayed on them.
Chronic stress may be quietly reshaping your heart September 21, 2026
Chronic inflammation tied to stress, lifestyle, mental health, and socioeconomic conditions may silently change the heart for years before any symptoms appear. People with the highest inflammation levels faced a 43% greater risk of heart attack and stroke, raising hopes that earlier testing and anti-inflammatory treatments could help prevent serious heart disease.
Hidden gut defect that may explain why IBD keeps coming back September 20, 2026
Researchers have uncovered a hidden molecular warning sign of inflammatory bowel disease (IBD) that can linger even when patients feel well and appear to be in remission. By studying around 900 human gut biopsies and patient-derived mini-intestines, the team found that intestinal cells can remain unusually primed to die, creating a “smoldering” defect that may […]
Scientists solve a 50-year mystery and discover a new human blood group September 19, 2026
Scientists have identified the genetic cause behind the mysterious AnWj blood group antigen, solving a puzzle that began in 1972 and establishing a new blood group system called MAL. The discovery could make it much easier to find extremely rare AnWj-negative patients and donors and protect them from potentially dangerous transfusion reactions.
Scientists find how “zombie” cells fuel inflammation as we age September 14, 2026
Scientists discovered that aging cells can use malfunctioning mitochondria to unlock inflammatory genes and keep the immune system stuck in a prolonged state of alert. Blocking one part of this process reduced inflammation and improved healthy aging in mice, suggesting a promising new strategy for fighting age-related decline.